Found: 16
Select item for more details and to access through your institution.
Effect of noncompetitive proteasome inhibition on bortezomib resistance.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2351, doi. 10.1038/leu.2013.152
- By:
- Publication type:
- Article
CyBorD induction therapy in clinical practice.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 3, p. 375, doi. 10.1038/bmt.2014.288
- By:
- Publication type:
- Article
Early relapse after single auto-SCT for multiple myeloma is a major predictor of survival in the era of novel agents.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 2, p. 204, doi. 10.1038/bmt.2014.237
- By:
- Publication type:
- Article
Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 1, p. 95, doi. 10.1038/bmt.2014.226
- By:
- Publication type:
- Article
Rational therapy targeting the initial genetic event in multiple myeloma: FGFR3 as a drug target in t(4;14) myeloma.
- Published in:
- European Journal of Haematology, 2003, v. 70, n. 4, p. 268, doi. 10.1034/j.1600-0609.2003.10910.x
- By:
- Publication type:
- Article
Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Oncolytic virotherapy for multiple myeloma using a tumour-specific double-deleted vaccinia virus.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Expression and mutation status of candidate kinases in multiple myeloma.
- Published in:
- 2008
- By:
- Publication type:
- Correction notice
Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution.
- Published in:
- 2007
- By:
- Publication type:
- letter
Expression and mutation status of candidate kinases in multiple myeloma.
- Published in:
- 2007
- By:
- Publication type:
- letter
Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 study.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2005, v. 36, n. 9, p. 793, doi. 10.1038/sj.bmt.1705131
- By:
- Publication type:
- Article
Altered gene expression in cells from patients with lysosomal storage disorders suggests impairment of the ubiquitin pathway.
- Published in:
- Cell Death & Differentiation, 2007, v. 14, n. 3, p. 511, doi. 10.1038/sj.cdd.4402013
- By:
- Publication type:
- Article
P14.122 Integrin α5 is a poor prognostic factor in patients with glioblastoma treated by the Stupp protocol.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii97, doi. 10.1093/neuonc/noz126.357
- By:
- Publication type:
- Article